Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants
Name | Selegiline 1.25mg oral lyophilisates sugar free |
BNF code | 0409010T0AAAKAK |
Virtual Therapeutic Moiety | Selegiline |
Date identifier became valid | 7 Jul 2023 |
Previous product identifier | 323155008 |
Basis of preferred name | rINN - Recommended International Non-proprietary |
Date of name applicability | 10 May 2004 |
Previous name | Selegiline 1.25mg oral lyophilisates |
Basis of previous name | rINN - Recommended International Non-proprietary |
Reason for name change | Other |
Prescribing status | Valid as a prescribable product |
Sugar free | ✓ |
Gluten free | ✗ |
Preservative free | ✗ |
CFC free | ✗ |
Non-availability | Actual Products not Available |
Non-availability status date | 7 May 2020 |
Dose form | Discrete |
Unit dose form size | 1.000 |
Unit dose form units | tablet |
Unit dose unit of measure | tablet |
Virtual Product Ingredient | |
---|---|
Ingredient | Selegiline hydrochloride |
Basis of pharmaceutical strength | Based on Ingredient Substance |
Strength value numerator | 1.250 |
Strength value numerator unit | mg |
Ontology Drug Form & Route | |
Form & Route | lyophilisate.oromucosal |
Dose Form | |
Formulation | Oral lyophilisate |
Drug Route | |
Route | Oromucosal |
Controlled Drug Prescribing Information | |
Controlled Drug category | No Controlled Drug Status |
Virtual Medicinal Product Packs | |
Selegiline 1.25mg oral lyophilisates sugar free 30 tablet |
dm+d data retrieved from TRUD: release NHSBSA_5.0.0_20250505000001, imported on 5th May 2025 at 04:58:39.